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Abstract
Background:  The purpose was to examine how General Practitioners (GPs) use clinical
information and rules from guidelines in their decisions on drug treatment for high cholesterol
values.
Methods: Twenty GPs were presented with six case vignettes and were instructed to think aloud
while successively more information about a case was presented, and finally to decide if a drug
should be prescribed or not. The statements were coded for the clinical information to which they
referred and for favouring or not favouring prescription.
Results: The evaluation of clinical information was compatible with decision-making as a search
for reasons or arguments. Lifestyle-related information like smoking and overweight seemed to be
evaluated from different perspectives. A patient's smoking favoured treatment for some GPs and
disfavoured treatment for others.
Conclusions: The method promised to be useful for understanding why doctors differ in their
decisions on the same patient descriptions and why rules from the guidelines are not followed
strictly.
Background
The medical decision examined in our study is whether or
not to initiate drug treatment for high cholesterol values.
The topic has been the focus of much debate on the
grounds that the proportion of individuals with elevated
cholesterol values is high in most Western populations,
and that the costs for treating all these people with drugs
life-long would be enormous, with a marginal benefit in
risk reduction for the majority of them [1-3]. The current
Swedish guidelines [4] from 2003 are national applica-
tions of the recommendations on coronary prevention of
the Third Joint European Task Force [5]. In sum, the
national guidelines define a total cholesterol value above
5 mmol/l and/or an LDL value above 3 mmol/l as hyper-
cholesterolaemia and the same values as the goals for
treatment. As a comparison, the American guidelines are
more aggressive in terms of treatment goals for patients
with established coronary heart disease and they are more
focused on the LDL levels [6]. The Swedish guidelines
identify two group of patients that in general should be
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offered pharmacological treatment after a sufficiently long
trial of life style intervention: the individuals with already
established cardiovascular disease (so called secondary
prevention cases) or diabetes. A third group that in gen-
eral should receive medication are patients with familial
hyperlipidaemia (FH). For the remaining individuals with
a total cholesterol above 5 mmol/l and/or LDL above 3
mmol/l (primary prevention), the same guidelines sug-
gest that the decision to recommend a drug or not should
be based on an estimate of the combined risk stemming
from the individual's different risk factors. More specifi-
cally, the recommendation is to make a numerical risk
estimate of the risk for coronary heart disease (CHD)
within the next ten years (or the risk projected to 60 years)
with a cut-off value at 20%. Based on the results from epi-
demiological studies, algorithms for arriving at such risk
estimates (e.g. Anderson et al. [7]) have been developed
and are available, for instance, as charts in pocket format
for doctors.
Thus, the decision-making task can be carried out as fol-
lows. The first step is to decide whether the patient case is
an instance of secondary prevention, diabetes or FH, and
if not, to estimate the numerical risk for coronary disease
within ten years. A risk above 20% would justify pharma-
cological treatment, given that life style intervention has
been tried for a sufficiently long period.
In this study we address the question of how General Prac-
titioners (GPs), who manage most of the cholesterol test-
ing and treatment in Sweden, make such decisions when
guidelines are not physically available to them. We will try
to highlight the decision-making by examining how it is
affected by clinical variables describing the patient and by
medical knowledge and decision rules on behalf of the
doctors. The reason for studying decisions without access
to written guidelines is that as experienced GPs (in the
case of three of us), we have found that this is how deci-
sions on cholesterol treatment are usually made. Further-
more, in a previous study concerning the ability of GPs to
make numerical estimates of future cardiovascular risks,
we asked the GPs if they had access to any tool for making
numerical risk estimates at their clinic [8]. Only nine out
of 84 respondents said they had such a tool. GPs' judg-
ments regarding cholesterol treatment have been studied
previously using Clinical Judgment Analysis, CJA (for a
description of this research paradigm, see Cooksey [9], for
an overview of the medical applications, see Wigton [10]).
The variation among doctors with respect to which infor-
mation about the patient influenced their decisions most
(strategies) seemed to be high [11], and the strategies were
not in accordance with the guidelines for a substantial
proportion of the doctors [12]. The number of patient var-
iables (cues) that influenced the decisions was two or
three for most doctors [11,12]. About one-fourth of the
doctors did not include coronary heart disease in the
irjudgments [12], in spite of the central role of this risk
factor according to the guidelines. The statistical model-
ling with CJA describes individual doctors' judgment strat-
egies added together for a set of cases, but does not give
direct information about the kind of rules or medical
knowledge that the participants use in their decisions. In
the present study we used the think-aloud technique [13]
in order to learn more about the use of medical knowl-
edge and rules. In addition, with this technique we are
better able to study the decisions for individual patient
cases. In a previous paper, based on the present data [14],
we coded the think-aloud protocols for preferences con-
cerning two decision alternatives, prescribing a choles-
terol lowering drug or not doing so. The codings proved
to be reliable. They also appeared to be valid in the sense
that there was good agreement on how think-aloud data
and rating data, both concerning preferences for prescrib-
ing and not prescribing, described the decision process
over time for different simulated patient cases. In the
present study we link such preference data from think-
aloud protocols to different kinds of information describ-
ing the patient cases. We also investigate how the use of
rules and guidelines can be inferred from the think-aloud
protocols.
Our first set of research questions concerned how differ-
ent kinds of information about the patient (e.g. age, sex,
previous diseases and laboratory tests) relate to the deci-
sion to prescribe a drug or not to do so. First, we estimated
the importance of the individual information categories
by counting the total number of times they had, according
to the coding of the verbal protocols, been valued in a
positive or negative direction in relation to the decision at
hand. Second, in order to get an idea about why different
doctors reach different decisions when presented with
identical case information, we made the following analy-
ses. For each of the patient cases separately, the subgroup
who decided to prescribe was compared with those with
an opposite decision regarding how often they valued dif-
ferent information categories. Third, to further under-
stand how the participants differed in their judgments, we
examined which kinds of specified information about a
patient (e.g. male sex) are the most likely to lead to disa-
greement, i.e. to be judged in a positive direction by some
participants and in a negative direction by others.
Disagreement about the evaluation of data on a given var-
iable may result from different cut-off values, e.g. for the
cholesterol variable. A certain value can be considered
high for one participant and thus speaking for drug treat-
ment. The same cholesterol value may be considered
almost normal by another participant and thereby speak-
ing against drug treatment for the same patient. The age
variable may also be associated with disagreement due toBMC Medical Informatics and Decision Making 2004, 4:23 http://www.biomedcentral.com/1472-6947/4/23
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different cut-off values. A higher age is generally associ-
ated with a higher risk, but there is a lack of evidence for
the potential benefit of treating the oldest age groups, and
this may introduce different cut-off values for different
doctors.
Disagreement may also be caused by what might be called
different perspectives. If we take smoking as an example
all doctors should recognize smoking as a factor associ-
ated with an increase in future cardiovascular risk, and
should accordingly make statements with a positive direc-
tionality for drug treatment. On the other hand, some
doctors in some situations may regard actions aimed at
smoking cessation as more beneficial than cholesterol
reduction, which may give smoking a negative direction-
ality in relation to drug treatment. Overweight can be
regarded in the same way, i.e. as an indicator of drug treat-
ment or as indicating change of life style as preferable to
drug treatment. Thus, there are two alternative treatment
philosophies – drug treatment or life style change – which
in turn may be associated with opposite evaluations of the
same data in relation to drug treatment. To the extent that
these philosophies in fact are associated with different
evaluations, one may regard them as different perspectives
where certain data (e.g. smoking) are seen from different
angles, as risk indicators or as entities that could be
changed through patient's own efforts (i.e. by changing
life style) as a means to treat the his or her health problem.
The latter perspective may also be associated with some-
what moralistic evaluations, e.g. that overweight or smok-
ing is the patient's own choice or own "fault", which in
turn would decrease the inclination to initiate drug treat-
ment. Some evidence for this conjecture comes from a CJA
study by Evans et al [11]. They interviewed the doctors
after the case presentations regarding which factors they
thought had influenced their judgment most. The GPs
stated that they were generally less likely to treat people
who were overweight. Most were also less likely to treat
smokers, but some had the opposite policy. Those less
likely to treat smokers were also less likely to treat obese
patients. The traditional medical risk factors like diabetes
and hypertension may also be associated with either the
risk increase perspective or an alternative perspective,
where other variables than the cholesterol level are in
focus for treatment. Such an alternative perspective
should be more likely with a poor control of the blood
pressure or diabetes parameters. As this was hardly the
case with our case vignettes, and as the moralistic perspec-
tive is more likely with life style factors, we expected disa-
greement to be more frequent with life style variables than
with traditional medical factors.
Our second set of research questions concerned the use of
rules, and the concept of risk as shown in the verbal pro-
tocols. Six patient cases were chosen that included two
high-risk patients (secondary prevention or diabetes) for
whom the guidelines can be transferred to a simple deci-
sion rule (e.g. "patients with elevated cholesterol values
and previous coronary heart disease should have drug
treatment recommended"). Our question was how fre-
quently such decision rules were in the verbal protocols
and their content in relation to practice guidelines for ele-
vated blood lipids. For the remaining four cases (primary
prevention) no such simple guideline-based rule can be
applied and instead, a numerical risk calculation is sug-
gested. We examined the extent to which references to risk
estimates were made in the think-aloud protocols. For
both secondary and primary prevention cases we were
interested in determining how the decisions corre-
sponded to what is indicated by guidelines and risk
algorithms.
In sum, our research questions concerned: Importance of
information (which categories of information about the
patients seem to be most important for the decisions?).
Patterns of importance for "Yes" and "No" decisions
(when each case is analyzed separately, can we get an idea
of the reasons behind different decisions by comparing
the information evaluation for doctors who chose pre-
scription with those with the opposite decision?). Disa-
greement (which categories of information give rise to
disagreement?). Use of rules (their frequency and con-
tents). Risk estimation (for cases that should be decided
by use of a numerical risk calculation, according to the
guidelines, how frequent is a referral to the concept of risk
estimation in the verbal protocols?).
Our approach to analyse think-aloud protocols in a med-
ical decision task for the relative importance of different
information categories and the amount of disagreement
in the evaluation of these categories has not been tried
before as far as we know. We believe that the results can
be useful for understanding why doctors reach different
decisions in response to the same patient cases and why
they often do not act in accordance to guidelines. This
knowledge should be useful as an aid to design guidelines
and teaching.
Methods
Design
The 20 participants received the same six patient cases and
the order of the cases was the same for all participants.
Cases with "Yes"- and "No" decisions as the recom-
mended treatment according to the guidelines were mixed
as evenly as possible. Ten of the participants were ran-
domly assigned to a condition where, in addition to
thinking aloud, they also rated their willingness to pre-
scribe a drug at regular intervals during each case. As was
described in a previous paper [14], this group did not dif-
fer from the group without the rating task as regards theBMC Medical Informatics and Decision Making 2004, 4:23 http://www.biomedcentral.com/1472-6947/4/23
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prescription decision or the directionality in the think-
aloud data. In the present paper the think-aloud data from
these two groups have been compiled, whereas the analy-
ses of the rating data are confined to this previous paper.
Participants
Twenty GPs working in the southern Stockholm area par-
ticipated. There were 10 males and 10 females. Their ages
varied between 34 and 60 years (M = 48.3) and they had
practiced between one and 22 years (M = 11.4) as special-
ists in family medicine. A total of 36 doctors were con-
tacted by telephone. They were selected so as to have a
relatively even distribution across different districts in the
area and according to gender, but the selection was not
random. Twenty-four agreed to participate, but before the
session four of these later declined to participate.
Cases
Six clinical cases were selected from an original set of 40
authentic cases with cholesterol values above normal (at
least 5.5 mmol/L). The original set was used in a Clinical
Judgment Analysis design with a different sample of doc-
tors and is described in Backlund et al [12]. Two of the
cases, GM (with diabetes mellitus) and AR (with angina
pectoris), were obvious high-risk patients and it would be
reasonable to use the guidelines in a straightforward man-
ner and recommend treatment for these cases (under the
assumption that lifestyle modification had already been
tried). Case SH was distinguished by the absence of risk
factors other than a moderate increase in cholesterol level,
and it would therefore be reasonable to refrain from drug
treatment. In the remaining three cases (IS, TW and PU)
additional risk factors existed such as smoking and hyper-
tension, and the recommended line of management
would be to let the decision be guided by a numerical esti-
mate of the future risk for coronary heart disease. The
presently available risk-charts that are referred to in the
Swedish [4] and European guidelines [5] indicate a 10–
20% ten-year risk for case IS (treatment not justified), and
a 20–40% risk for case TW (treatment justified). For case
PU the calculated risk is 10–20%, which would suggest
refraining from drug treatment. However, case PU had a
strong family history of coronary heart disease, which is
an important risk factor although it is not directly
included in the chart. A decision to prescribe a drug is
probably justified for this case. Case SH had a calculated
risk of 5–10%. For all six cases lifestyle intervention as
well as advice concerning diet and exercise had been tried
for at least six months before the visit in question.
The different kinds of clinical information presented on
the six successive screens were divided time-wise in the
same way for all six cases. The order in which this infor-
mation was presented was arranged so as to be as realistic
as possible in relation to clinical practice (including how
patient cases are described in written referrals to other
clinics and in clinical conferences and tutoring). Table 1
shows case IS as it was presented to participants in the
study. All previously shown information about a case was
repeated on the later screens to reduce and control for
memory effects. This part of the text was placed at the top
of the screen and was a different colour.
Procedure
The study was conducted at the doctor's office or in a
room nearby. All visits and recordings were made by one
of the authors (LB). The cases were presented on a compu-
ter screen (Software Question Asker™ (QA) [15]. In the
course of six screens, more clinical information was grad-
ually added to the case. The participants were instructed
Table 1: Example of a case (IS)
Screen Information
1 The patient is a 67-year-old woman whose recent cholesterol value was 7.3 mmol/L. She has had the diagnosis hypercholesterolaemia for 
two years. She has been given advice concerning diet but she has not been prescribed a cholesterol-lowering drug. Her cholesterol value 
has decreased from an initial value of 7.8 mmol/L
2 The patient has been on medication for hypertension for 10 years (Seloken ZOC* 50 mg and Plendil** 5 mg). She is now on a visit to 
check her blood pressure and hypercholesterolaemia.
3 The patient has no other known diseases apart from osteoarthritis of her knees. Her mother suffered from hypertension and reached the 
age of 84 years.
4 The patient is a non-smoker. She very seldom drinks alcohol. She does not exercise on a regular basis but she is fond of taking walks.
5 Physical examination: Good general condition. A few kilograms overweight. Blood pressure 145/75. Heart and lung auscultation normal.
6 Laboratory values: Total cholesterol 7.3 mmol/L. LDL 5.4 mmol/L. HDL 1.2 mmol/L. Triglycerides 1.6 mmol/L. TSH, creatinine and liver-
function tests were normal.
7 Would you prescribe a cholesterol-lowering drug for this patient?
Yes NoBMC Medical Informatics and Decision Making 2004, 4:23 http://www.biomedcentral.com/1472-6947/4/23
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that authentic cases of hypercholesterolaemia would be
presented and that their task was to voice aloud all their
thoughts about the case, and that each case would end
with the question as to whether or not they would pre-
scribe a drug for this patient. They controlled the shift to
a new screen by using a mouse click. When the participant
had finished a screen, he or she clicked on a "continue"
button. If a participant was silent for more than 10–15
sec, he or she was reminded to voice aloud all thoughts
about the information presented.
The study was approved by the local ethics committee.
Response measures and coding of data
Decision
Each case ended with a screen with the following ques-
tion: "Would you prescribe a cholesterol-lowering drug
for this patient?" The participant responded by clicking on
one of two response alternatives, "Yes" or "No".
Think-aloud protocols
The sessions were tape-recorded. A secretary then tran-
scribed the recorded sessions into a written, word-by-
word format. The protocols were segmented into state-
ments. The next step was to categorize the statements into
one of ten categories concerning the general characteristic
of the statement (cp. Cognition Categories): Attention,
Evaluation, Rule, Explanation, Action pharmacological
treatment, Action non-pharmacological treatment, Action
other, Want of information, Rating (valid for the ten par-
ticipants with an additional rating task) and Other. The
set of categories is described in more detail in Backlund et
al [14]. Each statement was also assigned one of the values
+, -, 0 or x, denoting directionality in relation to the deci-
sion task (to prescribe or not to prescribe). The majority
of statements that could be assigned a positive or negative
directionality had been categorized into either "evalua-
tion" or "application of a rule". However, the most fre-
quent outcome of the categorization was "attention" (the
participant read the information aloud, or retrieved it
from memory, with neutral or no reformulation), and no
directionality could be assigned (i.e. coded as "x"). Zero
directionality indicated an explicit statement that the
information was neutral in relation to the decision.
Finally, each statement was coded with respect to the
information referred to. A certain information category
could be coded more than once for a given doctor and a
given case, unless we regarded the statement as a mere rep-
etition (close in time and identically or almost identically
phrased as an earlier statement). The original set con-
tained 21 information categories within the areas of back-
ground data, medical conditions, previous diseases,
lifestyle factors, physical examination and laboratory
tests.
Results
Reliability of the coding system
Two of the authors (LB and YS) independently coded the
protocols from the first six participants. Reliability was
computed separately for directionality (+, -, 0 or x) and for
information category (one of 21) as the percentage of
statements that were coded into the same directionality/
information category. For these first six participants, the
inter-judge reliability was 92% for directionality and 94%
for information category. The reliability measures were
considered to be satisfactory and therefore only one of the
authors (LB) performed the remaining coding.
Information categories
The original set of 21 different information categories was
reduced to eleven. When we ranked the information cate-
gories with regard to the frequency of positive or negative
evaluations there was a great leap between weight (fre-
quency 14 and rank eleven) and triglycerides (frequency
four and rank twelve). We therefore excluded triglycerides
and information categories with fewer evaluations. Exam-
ples of such excluded categories were information about
physical examination of the heart and lungs (normal out-
come for each of the cases) and test results concerning
liver or thyroid function. The remaining eleven informa-
tion categories were Cholesterol, LDL (low density lipo-
protein), HDL (high density lipo-protein), weight, smok-
ing, CHD (coronary heart disease), diabetes, hyperten-
sion, heredity, sex and age.
Treatment decisions
Table 2 summarizes the information for each case as
regards these eleven categories and shows the number of
doctors who decided to prescribe a drug as well as the rec-
ommended decisions according to the Swedish guide-
lines. The frequency varied from zero (case SH) to 17 (case
AR). "Yes"-decisions and "No"-decisions were equal in
frequency when summarized over participants and cases.
Figure 1 shows that the majority of doctors chose to pre-
scribe for two, three or four of the six cases. No participant
decided to prescribe for all six cases and one participant
chose not to prescribe for any of the cases.
Importance of information
Figure 2 shows that information about cholesterol was
evaluated most frequently, both in the positive and the
negative direction. It can also be seen that positive evalu-
ations were more frequent than negative ones, except for
sex, age and weight, which in part can be due how the
final question was worded. For each of the 20 participants
we calculated the number of evaluative statements (i.e.
with a positive or negative directionality) for each of the
eleven information categories as an index of the impor-
tance of the information category. A 2 (Direction: Posi-
tive/Negative) × 11 (Information category 1–11) × 6BMC Medical Informatics and Decision Making 2004, 4:23 http://www.biomedcentral.com/1472-6947/4/23
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(Case 1–6) ANOVA with three within-group variables and
the number of evaluated statements as dependent variable
was performed. The main effect of Information category
was highly significant, F (4.4; 84.1) = 8.80, p < .01, as was
Information category × Case interaction, F (9.1; 172.2) =
11.80, p < .01. (In ANOVA with repeated measures in this
study, the degrees of freedom were adjusted according to
the Greenhouse-Geisser Epsilon). Thus, as could be
expected, the different information categories were evalu-
ated unequally often, and the pattern of relative impor-
tance differed in the six individual patient cases. All other
main effects and interaction effects were also significant
with p < .01.
Patterns of importance for "Yes" and "No" decisions
In the following, the six patient cases will be analysed sep-
arately. This may allow us to detect possible differences in
the pattern of importance between different information
categories for participants who decided to prescribe a drug
Table 2: Characteristics of the cases and the number of doctors who decided to prescribe a drug
Information category Case
IS GM TW SH AR PU
A g e 6 75 36 75 15 64 1
Sex Female Female Male Female Male Female
Heredity Slight Slight No Slight No Strong
Hypertension Yes No Yes No No No
Diabetes No Yes No No No No
C H D N oN oN oN oY e sN o
Smoking No No Yes No No No
Overweight Slight No No No Yes No
HDL 1.2 1.1 1.0 1.0 0.9 1.2
LDL 5.4 4.1 3.6 4.3 4.3 5.3
Cholesterol 7.3 5.9 6.0 6.5 5.9 7.2
Decision according to guidelines No Yes Yes No Yes No?*
Percentage of doctors who decided to prescribe 60 50 35 0 85 70
The number of participants with 0–6 "Yes"-decisions Figure 1
The number of participants with 0–6 "Yes"-decisions 
The number of participants with 0–6 "Yes"-responses, out of 
6 possible, to the question whether or not to recommend 
drug treatment for the different patient cases.
0
1
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4
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6
0123456
Nr of "Yes"-decisions
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Relative importance of the different information categories Figure 2
Relative importance of the different information cat-
egories. For each of the information categories, its impor-
tance for the decision to recommend drug treatment or not, 
was defined as the mean number of statements per partici-
pant that were coded with a positive or negative directional-
ity in relation to the treatment decision.
0 0,5 1 1,5 2 2,5 3
Age
Sex
Heredity
Hypertension
Diabetes
CHD
Smoking
Weight
HDL
LDL
Cholesterol
Mean Nr of evaluations
Pos
NegBMC Medical Informatics and Decision Making 2004, 4:23 http://www.biomedcentral.com/1472-6947/4/23
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and those who made the opposite decision. For each case
the number of evaluative statements was the dependent
variable in a 2 (Decision: Yes/No) × 11 (Information cat-
egory 1–11) × 2 (Direction: positive/negative) ANOVA,
with the first as a between-group variable and the latter
two as within-group variables. The statistical effects are
summarized in Table 3.
The main effect of Decision was not significant in any of
the cases, indicating that there was no evidence of an asso-
ciation between the number of evaluative statements and
decision outcome. For four of the cases the effect of Direc-
tion was significant, indicating that positive and negative
statements were of unequal frequency. Except for case SH
(the case for which all 20 participants decided not to
prescribe), positive statements were more frequent than
negative ones. For all six cases the different information
categories were evaluated unequally often (i.e. main effect
of Information). A significant Decision × Direction Inter-
action, indicating that the decision to prescribe or not to
prescribe was associated with different distributions
between positive and negative statements, was found in
only two of the cases. Direction × Information Interaction
was significant or nearly significant for all five cases, sug-
gesting that the distribution of positive and negative direc-
tionality was unequal across the different information
categories.
The most interesting part of these analyses, however, is
whether different decisions were associated with different
evaluative patterns across the information categories.
Statistically, this corresponds to two- or three-way interac-
tion effects including Decision and Information.
A significant Decision × Information interaction for a case
would indicate that participants with a "Yes"-decision had
their number of evaluative statements differently distrib-
uted across Information categories compared to partici-
pants with a "No"-decision, regardless of whether the
direction was positive or negative. The three-way interac-
tion includes the directionality of the statements as well.
As can be seen from Table 3, most of these interaction
effects were non-significant. However, the number of eval-
uations per patient case is probably too small to give
enough power for such interaction effects. Three of the
cases will be selected to illustrate how this approach may
provide hypotheses about information strategies.
Case IS represents a 67-year-old female with hypertension
as a central risk factor in addition to her cholesterol eleva-
tion. She also had a modest heredity. As Figure 3 shows,
the 12 participants who decided to prescribe had more
positive evaluations of the central risk factor hyperten-
sion. In addition, the group who decided not to prescribe
seemed to make negative evaluations of information
about heredity, suggesting that this information may have
been an "argument" against pharmacological treatment
for some of the participants in the "No"-subgroup.
Case TW (Figure 3) represents a case with several risk fac-
tors in addition to cholesterol elevation (e.g. smoking and
hypertension). An important difference between the
groups may be that the "No"-group evaluated the patient's
relatively low cholesterol level more often and in the neg-
ative direction in relation to pharmacological treatment.
Case AR (Figure 3) represents a case with CHD (in this
case angina pectoris). A comparison between the response
groups suggests that greater emphasis was put on CHD by
the "Yes"-group, and at the same time there was a negative
evaluation, as regards pharmacological treatment, of the
patient's (over-) weight by some participants in the "No"-
group.
Thus, an analysis of the response patterns for these three
cases suggests that the "Yes" and "No"-groups differed not
Table 3: The frequency of statements with positive or negative directionality. Summary of test statistics The table summarizes the 
results of ANOVA with the frequency of evaluative statements as dependent variable and Decision, Direction and Information as 
independent variables. F-values are given with the results of significance tests within parentheses.
Case
Statistical effects IS GM TW SH AR PU
Decision .73 (ns) 1.86 (ns) .87 (ns) * .01 (ns) .01 (ns)
Direction 10.54 (<.01) 3.98 (.06) 6.09 (<.05) 7.39 (<.01) .84 (ns) 8.31 (<.01)
Information 7.03 (<.01) 16.80 (<.01) 11.17 (<.01) 1.99 (.09) 5.87 (<.01) 11.15 (<.01)
Decision × Direction 2.55 (ns) .69 (ns) 7.89 (<.05) * 12.65 (<.01) 2.42 (ns)
Direction × Information 6.40 (<.01) 5.78 (<.01) 4.57 (.01) 2.18 (.07) 6.28 (<.01) 12.90 (<.01)
Decision × Information 2.06 (<.09) .61 (ns) .74 (ns) * 4.38 (<.01) 1.15 (ns)
Decision × Direction × 
Information
1.54 (ns) .85 (ns) 2.18 (ns) * 3.05 (<.05) 1.09 (ns)BMC Medical Informatics and Decision Making 2004, 4:23 http://www.biomedcentral.com/1472-6947/4/23
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Patterns of importance for "Yes" and "No" decisions Figure 3
Patterns of importance for "Yes" and "No" decisions. As in Figure 2, the mean numbers of statements with a positive 
and negative directionality are shown for the 11 different information categories. In Figure 3, the patterns of positive and nega-
tive evaluations across the information categories are shown separately for the subgroups with "Yes" decisions and "No" deci-
sions, respectively. Three of the six patient cases are shown.
Case IS "Yes", N=12
0,0 0,5 1,0 1,5 2,0
Mean Nr of statements
Pos
Neg
Case IS "No", N=8
0,0 0,5 1,0 1,5 2,0
Age
Sex
Heredity
Hypert
Diabetes
CHD
Smoking
Weight
HDL
LDL
Cholesterol
Case TW "Yes", N=7
0,0 0,5 1,0 1,5 2,0
Mean Nr of statements
Pos
Neg
Case TW "No", N=13
0,0 0,5 1,0 1,5 2,0
Age
Sex
Heredity
Hypert
Diabetes
CHD
Smoking
Weight
HDL
LDL
Cholesterol
Case AR "Yes", N=17
0,0 0,5 1,0 1,5 2,0
1
2
3
4
5
6
7
8
9
10
11
Mean Nr of statements
Pos
Neg
Case AR "No", N=3
0,0 0,5 1,0 1,5 2,0
Age
Sex
Heredity
Hypert
Diabetes
CHD
Smoking
Weight
HDL
LDL
CholesterolBMC Medical Informatics and Decision Making 2004, 4:23 http://www.biomedcentral.com/1472-6947/4/23
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only in how much they evaluated the central risk factor(s)
(in addition to cholesterol elevation) as favouring drug
treatment but also in that the "No"-group seemed to have
identified at least one information category as evidence
against treatment. As regards the remaining cases, the
evaluative pattern for case PU (young woman with severe
heredity for CHD) could be interpreted in a similar way,
with the patient's (young) age as an argument against
drug treatment, whereas case GM (diabetic case) did not
invite any such interpretation. For Case SH, no compari-
son between response groups could be made as all partic-
ipants decided not to prescribe.
Disagreement
We defined agreement as the degree to which the same
information about a patient case was evaluated with the
same directionality. We hypothesized that disagreement
would be more common for information about lifestyle-
related factors like smoking and weight than would be the
case for medical conditions like hypertension and diabe-
tes. There was only one case with a clear overweight and
one case where the patient smoked, and the number of
evaluative statements concerning these two information
categories was therefore rather low. Regarding case TW's
smoking, there were 21 statements with a positive direc-
tion and ten with a negative direction. For case AR's over-
weight there were three positive and six negative
statements. For hypertension, each of the cases had either
only positive or only negative directions (or no statements
with directionality at all). The same pattern was found for
diabetes and CHD, except that for diabetes two statements
concerning case GM were negative compared to 24 state-
ments with positive directionality, and for CHD (case AR)
one statements was negative whereas 31 were positive.
Thus, with minor exceptions the participants agreed on
the evaluations of these three information categories. The
data were consequently in line with our hypothesis.
There were few evaluative statements concerning the sex
of the cases. With one single exception all statements were
negative and concerned female cases, which is in line with
the known lower risk for female patients to suffer from
cardiovascular diseases. A corresponding tendency
towards positive evaluations of the male cases was not
clearly demonstrated in this material, which could suggest
a possible bias in how sex is evaluated as a risk factor. As
far as the age variable is concerned, there were both posi-
tive and negative statements (i. e. disagreement) for four
of the six cases, which was in accord with our expecta-
tions. Among the information categories concerning lab-
oratory values, cholesterol was evaluated most often by
far, with a fairly even distribution of positive (total 46)
and negative (total 39) statements. For at least four of the
cases, there were approximately the same numbers of pos-
itive and negative evaluations of the same cholesterol
value. In other words, according to our definition there is
evidence of disagreement among participants in the eval-
uation of the different cholesterol values.
At the level of individual participants, there were eleven
instances where doctors made both positive and a nega-
tive evaluation(s) of one case. Four of these eleven con-
cerned smoking, two cholesterol, two LDL and one each
of hypertension, coronary heart disease and diabetes.
Use of rules
A total of 32 statements (i.e. not more than 1.6 per partic-
ipant) were coded as rules. According to our judgment, 18
of these 32 statements were derived from or were compat-
ible with the guidelines (including those rules that were
not entirely correct in detail, e.g. regarding the cut-off lim-
its for LDL and HDL) and twelve of these 18 were a more
or less directly referring to secondary prevention or diabe-
tes (e.g "He has angina pectoris and should be below 5 in
cholesterol"). Examples of other contents for the
statements coded as rules were age limit for cholesterol
treatment, importance of looking for secondary hypercho-
lesterolaemia, the role of LDL/HDL ratio, priority of
smoking vs. pharmacological treatment, the desired
blood pressure value for diabetics blood pressure and the
cut-off value for ten-year risk for primary prevention. For
two of the patient cases (case GM with diabetes mellitus,
and case AR with a history of angina pectoris), the guide-
lines allow a simple decision rule to be applied. Of the 32
instances of reference to a rule, 24 were in connection
with these two patient cases.
Risk estimation
For the four primary prevention cases, IS, TW, SH and PU,
a number of statements referring to numerical risk esti-
mate (guidelines say 20% within the next ten years) could
have been expected. Only two participants referred to
numerical risk estimates.
Discussion
We discuss first how the doctors evaluated the available
information in relation to the decision to be made (i.e., in
terms of directionality). When each case was analyzed
separately, there was some evidence of different patterns
of information use shown by prescribers and non-pre-
scribers. The non-prescribers seemed to evaluate central
risk factors with a positive directionality less often than
prescribers, and they also appeared to identify at least one
information category that was given a negative direction-
ality. This is compatible with theories that describe deci-
sion-making as search for arguments or reasons for one or
the other decision alternative [16,17].
Paradoxically, the information categories that some doc-
tors used as arguments against  treatment were used asBMC Medical Informatics and Decision Making 2004, 4:23 http://www.biomedcentral.com/1472-6947/4/23
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arguments for treatment by other doctors. We interpret
this finding as showing that prescribing and not prescrib-
ing doctors evaluate given information from different per-
spectives, i.e., from different viewing angles that will put
different aspects of the given information in the fore-
ground and background, respectively [18]. If we take
smoking or overweight as examples, they could be seen as
risk indicators for CHD (which is what is naturally seen
from a drug treatment perspective) or as possibilities for
life-style change, which in turn will reduce the patient's
future coronary risk (which is what is naturally seen from
a life-style change perspective). It may be noted that the
doctors did in general not consider both ways of evaluat-
ing the information to assess their relative weight for and
against a decision to prescribe. Instead, only the aspects
supporting this decision or an alternative decision were
focused, which is in line with the assumption that the doc-
tors viewed the information from a certain perspective
that favoured the decision to be made. For example, we
can compare the protocol by participant 6 (decision Yes)
regarding Case AR: "He has angina and he has overweight
so I will treat him" with the protocol from participant 3
(decision No) regarding the same case: "I would like him
to reduce his weight first".
The use of life style factors as arguments for prescription
decisions was further illustrated in a separate analysis
based on the same verbal protocols that also include a
task where the doctors were asked to describe freely how
they usually reason when they meet patients with high
cholesterol values [19]. The protocols were coded for
knowledge of guidelines content and for arguments for
the decision to prescribe or not. In several instances the
doctor seemed to be fully aware of the contents of the
guidelines but still decided to refrain from a strict applica-
tion of it. The arguments for the decisions in these cases
often concerned life style factors like smoking or over-
weight – either as risk increasing factors or as alternative
strategies for intervention.
Disagreement was also shown for the age variable. Age is
generally considered as positively and monotonically
related to risk for future cardiovascular events. At the same
time, the guidelines make the reservation that the benefit
of giving drugs to very old people is unclear. As far as
young patients are concerned, the perspective of ten-year
risk appears to be too narrow. The recommended
procedure is to increase or project the age to 60 years in
order to estimate the risk [4,5]. For doctors with limited
experience in using the risk charts, this might be
confusing.
Cholesterol was another variable that was ambiguous
which could be explained in part by the selection of
patient cases. Four of the six cases had cholesterol values
in the range of 5.0–6.5 mmol/L, which is often labeled as
a mild elevation. This might have formed the basis for
negative evaluations, i.e. when a value was close to nor-
mal a decision to refrain from drug prescription could
have been favored. A few participants also commented
that the cholesterol values were lower than they had
expected, or lower than those of their own patients.
Ambiguity in the decision situation due to seeing the situ-
ation in terms of different treatment perspectives (relevant
for life style factors) or different ideas about the optimal
cut-off points (relevant for age and laboratory values)
could possibly be reduced by clearer guidelines, which in
turn accentuate the need for more research on a number
of issues. These issues include the role of life-style factors
for coronary heart disease, as well as how patients should
be motivated to change their life style, and cost-benefit
outcomes of using drug treatment of patients in different
age groups and with different cholesterol values.
We will now consider the second set of research questions
addressed in the present study, viz., the extent to which
the participants used certain rules as a basis for their deci-
sions. Based on the verbal protocols, the frequency of
statements classified as a rule was rather low, on average
1.6 per participant, and most of the rules concerned sec-
ondary prevention. Part of the explanation for the low
number of rules might be that the participants were uncer-
tain about the contents of the guidelines and were there-
fore less willing to talk about them. However, from our
separate coding for knowledge of guidelines content
referred to above [19], the conclusion was that the doctors
were in general well aware of the distinction between pri-
mary and secondary prevention.
The low frequency of statements containing a reference to
the risk concept could be explained in the same way, since
the participants had no immediate access to an aid for cal-
culating risk and were possibly unsure about the general
content of such an aid (e.g. the numerical value for ten-
year risk that would put the patient into a high-risk cate-
gory and justify drug treatment). Another reason for the
low number of rules might be that the instructions did not
encourage the participants to explain their decisions, but
simply to state aloud their thoughts about the presented
information, which is generally considered as the best
method to ensure that the verbal protocols reflect the cog-
nitive processes of interest [13]. A third possible influence
on the use of rules may be that cases that could be han-
dled in a straight-forward way by applying rules from the
guidelines were at he same time characterized by having
cholesterol values that were only marginally increased
above normal, which might have introduced conflict in
the decision situation.BMC Medical Informatics and Decision Making 2004, 4:23 http://www.biomedcentral.com/1472-6947/4/23
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From the view of evidence-based decisions and quality of
care, we can say that many of the cases were difficult and
that a considerable spread in the decisions was to be
expected. In fact, most of the participants found it difficult
to decide about several of the cases, which was evident
from interviews after the sessions. On the other hand, the
only case (SH) with a mild risk (5–10%) was correctly
judged by every participant as not being a candidate for
drug treatment. Case AR with angina pectoris represents a
decision situation where the guidelines could justify phar-
macological treatment in a straightforward manner, and
17 out of 20 chose to prescribe. The presence of diabetes
in Case GM could similarly justify drug treatment, but this
was the choice for only half the participants. The reason
could be that the recommendations concerning diabetes
as a risk factor in parity with coronary heart disease is
rather new. The Swedish guidelines were published in
1999 and the study was conducted in 2000.
One limitation of the present analyses is that most of the
conclusions are based on pooled data from groups of par-
ticipants, while the principal interest is in strategies at the
individual level. For example, the opposing evaluations of
the same patient data could only be demonstrated
between doctors due to the low number of patient cases.
After completion of the six cases, the participants were
asked to relate in their own words how they usually rea-
son regarding pharmacological treatment when
confronted with patients with high cholesterol values. In
a forthcoming paper these narratives will be analyzed at
the individual level as "scripts" for dealing with choles-
terol treatment. We will then have a better understanding
of how knowledge and guidelines in this area of medicine
are represented in memory, and how these cognitive struc-
tures are related to actual decisions and to the individual
doctor's think-aloud protocols from processing the cases.
Conclusions
In this study we have used a new method to analyse a
medical treatment decision. Verbal protocols were coded
with respect to how different patient variables seemed to
favor or not to favor the decision to prescribe a drug or
not. The method promised to be fruitful for understand-
ing why doctors reach different decisions in response to
the same patient descriptions and why guidelines are not
followed.
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